Ryasnyansky V.Yu., Shostka G.D., Anikonova L.I.
Nephrogenic anemia in patients receiving renal replacement therapy, pathogenesis and resistance
|
№1 / 2024
|
Avetisyan E.A., Kostritsa N.S.
Regional citrate anticoagulation with 4% sodium citrate
|
№2 / 2023
|
Trushkin R.N., Martov A.G., Sokolov S.A., Isaev T.K., Shcheglov N.E., Teikhrib P.P.
Method for surgical treatment of bladder cancer in patients with end-stage renal disease n renal replacement therapy with program hemodialysis simultaneously with the treatment and prevention of purulent pyelonephritis. Review of clinical cases
|
№2 / 2023
|
Trushkin R.N., Medvedev P.E., Isaev T.K., Klementieva T.M., Morozov N.V., Ivanov K.V.
Modern strategies for the treatment of patients with autosomal dominant polycystic kidney disease
|
№4 / 2022
|
S.I. Rey, N.V. Vasina, G.A. Berdnikov, L.V. Marchenkova, O. N. Kotenko
Organization of renal replacement therapy in emergency medicine in the context of new Coronaviral infection
|
№2 / 2021
|
S.I. Rey, N.V. Vasin, L.V. Marchenkov, O.N. Kotenko
Principles for the organization of renal replacement therapy in emergency medicine of the Moscow healthcare department
|
№4 / 2019
|
A.Yu. Nikolayev
Diagnostic errors and dialysis complications are factors of unfavorable prognosis in 4–5 stage chronic kidney disease
|
№2 / 2018
|
N.A. Mikhailova
Phosphate-binder therapy: economical aspects
|
№5 / 2013
|
M. Krstich, A.B. Zul'karnaev
Modern approaches to treatment of septic complications and urosepsis in patients with urological diseases on renal replacement therapy
|
№5 / 2013
|
D.E. Kutepov, A.V. Popov, A.V. Tsigankov, M.G. Vershinina
Long-term sustained low efficiency dialysis in treatment of patients with cardiorenal syndrome
|
№5 / 2011
|
P.A. Vorobev, L.J. Bezmelnitsyna
Epidemiology and quality of life in patients with chronic renal failire and anemia, receiving programm hemodyalisis. Part 1. Epidemiology and use of erythropoietin medications
|
№1 / 2011
|